Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E Frankel

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Journal of Biological Response Modifiers|October 1, 1985
Antibody-toxin hybrids: a clinical review of their useA E Frankel
Oncology (Williston Park, N.Y.)|May 1, 1993
Immunotoxin therapy of cancerA E Frankel
Targeted Diagnosis and Therapy|January 1, 1992
Genetically engineered toxins in perspectiveS Olsnes, A E Frankel
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1976
Nucleotide sequences in mouse DNA and RNA specific for Moloney sarcoma virusA E Frankel, P J Fischinger
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 1, 1991
Advances in immunotoxinsT N Oeltmann, A E Frankel
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
Immunotoxins: a clinical review of their use in the treatment of malignanciesA A Hertler, A E Frankel
Journal of Virology|January 1, 1977
Rate of divergence of cellular sequences homologous to segments of Moloney sarcoma virusA E Frankel, P J Fischinger
Cancer Investigation|January 1, 1991
Immunotoxins in the therapy of leukemias and lymphomasA A Hertler, A E Frankel
Apoptosis : an International Journal on Programmed Cell Death|January 24, 2004
Induction of apoptosis by tumor cell-targeted toxinsA Thorburn, J Thorburn, A E Frankel
Leukemia|September 21, 2007
Acute-myeloid-leukemia-targeted toxins kill tumor cells by cell-type-specific mechanisms and synergize with TRAIL to allow manipulation of the extent and mechanism of tumor cell deathH Horita, A E Frankel, A Thorburn
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Journal of Biological Response Modifiers|October 1, 1985
Antibody-toxin hybrids: a clinical review of their useA E Frankel
Oncology (Williston Park, N.Y.)|May 1, 1993
Immunotoxin therapy of cancerA E Frankel
Targeted Diagnosis and Therapy|January 1, 1992
Genetically engineered toxins in perspectiveS Olsnes, A E Frankel
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1976
Nucleotide sequences in mouse DNA and RNA specific for Moloney sarcoma virusA E Frankel, P J Fischinger
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 1, 1991
Advances in immunotoxinsT N Oeltmann, A E Frankel
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
Immunotoxins: a clinical review of their use in the treatment of malignanciesA A Hertler, A E Frankel
Journal of Virology|January 1, 1977
Rate of divergence of cellular sequences homologous to segments of Moloney sarcoma virusA E Frankel, P J Fischinger
Cancer Investigation|January 1, 1991
Immunotoxins in the therapy of leukemias and lymphomasA A Hertler, A E Frankel
Apoptosis : an International Journal on Programmed Cell Death|January 24, 2004
Induction of apoptosis by tumor cell-targeted toxinsA Thorburn, J Thorburn, A E Frankel
Leukemia|September 21, 2007
Acute-myeloid-leukemia-targeted toxins kill tumor cells by cell-type-specific mechanisms and synergize with TRAIL to allow manipulation of the extent and mechanism of tumor cell deathH Horita, A E Frankel, A Thorburn
Pageof 8